{"title":"Weight loss drugs may also treat addiction, Alzheimer’s, and heart disease","link":"https://arstechnica.com/health/2024/12/weight-loss-drugs-may-also-treat-addiction-alzheimers-and-heart-disease/","date":1734020457000,"content":"<p>One of Dr. Mo Sarhan’s patients was experiencing intense cravings for opioids and alcohol when the Florida-based doctor offered him a striking solution: the Eli Lilly weight-loss drug Mounjaro.</p>\n<p>“Within days, all of his cravings were gone and he was much more effective in his engagement and treatment. He’s done great since,” Sarhan says.</p>\n<p>Sarhan and his colleague Steven Klein at the Caron Treatment Centers in Florida and Pennsylvania have prescribed a range of so-called glucagon-like peptide-1 receptor agonists (GLP-1s) to treat addictions, using them alongside traditional therapies, to around 75 patients.</p><p><a href=\"https://arstechnica.com/health/2024/12/weight-loss-drugs-may-also-treat-addiction-alzheimers-and-heart-disease/\">Read full article</a></p>\n<p><a href=\"https://arstechnica.com/health/2024/12/weight-loss-drugs-may-also-treat-addiction-alzheimers-and-heart-disease/#comments\">Comments</a></p>","author":"Ian Johnston and Michael Peel, Financial Times","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"85bb015f383aca23b647e301e9a868cc5b877919f14922aa5c5cff4d40f0968b","category":"Tech"}